New Zealand’s Centre for
Adverse Reactions Monitoring has
issued an alert under the Trans-
Tasman Early Warning System after
receiving a report of a patient who
experienced serotonin syndrome
after taking just one dose of
escitalopram.
The patient experienced
symptoms within 24 hours of taking
the dose, and while the reaction
is a predictable consequence
of excess serotonin, the report
“highlights that this syndrome
may occur after only one dose
of an SSRI, without any other
concomitant medication”.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.